Another report used a rotenone-induced Complex I dysfunction model of PD, as well as postmortem brain tissue of PD patients, to show that α-syn (specifically, the S129 phosphomimetic and soluble oligomers) demonstrated strong but reversible binding to Tom20 and reduced Tom20 expression. The gene discussed is TOMM20; the disease is Parkinson disease.